Clinical Trial Update: Fluvastatin AmelIorates aTHerosclerosis Study [Phase 4]

View source ↗

Summary

This clinical trial update concerns a Phase 4 study of Fluvastatin for atherosclerosis and coronary heart disease sponsored by Beijing Anzhen Hospital. The curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• Lescol (fluvastatin)

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Coronary Heart Disease, Atherosclerosis | Phase 4 | Status: UNKNOWN